| Dr David C Dreyfuss, MD | |
|
161 Riverside Dr, Suite 105, Binghamton, NY 13905-4176 | |
| (607) 770-9471 | |
| (607) 797-4699 |
| Full Name | Dr David C Dreyfuss |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 43 Years |
| Location | 161 Riverside Dr, Binghamton, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053384297 | NPI | - | NPPES |
| 01028582 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 170145 (New York) | Primary |
| 2086S0129X | Surgery - Vascular Surgery | 170145 (New York) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Our Lady Of Lourdes Memorial Hospital Inc | 1254237779 | 226 |
News Archive
Physicians at Mayo Clinic's Florida campus are among the first in the nation to use a technique known as MRI-guided laser ablation to heat up and destroy kidney and liver tumors. So far, five patients have been successfully treated meaning no visible tumors remained after the procedure.
Ossianix, Inc. today announced a strategic research collaboration with Lundbeck A/S. This collaboration follows a previous investment in 2012. The collaboration uses Ossianix's innovative single domain antibody platform based on the shark VNAR structure and will focus on two projects.
Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.
Having problems with your health plan? If you speak up about it — or move on to another plan — you are a very unusual consumer, according to a new study.
Scientists know that age and weight are risk factors in the development of cancer. That should mean that whales, which include some of the largest and longest-lived animals on Earth, have an outsized risk of developing cancer.
› Verified 3 days ago
| Entity Name | Our Lady Of Lourdes Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629087580 PECOS PAC ID: 1254237779 Enrollment ID: O20031208000366 |
News Archive
Physicians at Mayo Clinic's Florida campus are among the first in the nation to use a technique known as MRI-guided laser ablation to heat up and destroy kidney and liver tumors. So far, five patients have been successfully treated meaning no visible tumors remained after the procedure.
Ossianix, Inc. today announced a strategic research collaboration with Lundbeck A/S. This collaboration follows a previous investment in 2012. The collaboration uses Ossianix's innovative single domain antibody platform based on the shark VNAR structure and will focus on two projects.
Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.
Having problems with your health plan? If you speak up about it — or move on to another plan — you are a very unusual consumer, according to a new study.
Scientists know that age and weight are risk factors in the development of cancer. That should mean that whales, which include some of the largest and longest-lived animals on Earth, have an outsized risk of developing cancer.
› Verified 3 days ago
| Entity Name | Empire Wound Physician Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093130742 PECOS PAC ID: 6406170497 Enrollment ID: O20150122001257 |
News Archive
Physicians at Mayo Clinic's Florida campus are among the first in the nation to use a technique known as MRI-guided laser ablation to heat up and destroy kidney and liver tumors. So far, five patients have been successfully treated meaning no visible tumors remained after the procedure.
Ossianix, Inc. today announced a strategic research collaboration with Lundbeck A/S. This collaboration follows a previous investment in 2012. The collaboration uses Ossianix's innovative single domain antibody platform based on the shark VNAR structure and will focus on two projects.
Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.
Having problems with your health plan? If you speak up about it — or move on to another plan — you are a very unusual consumer, according to a new study.
Scientists know that age and weight are risk factors in the development of cancer. That should mean that whales, which include some of the largest and longest-lived animals on Earth, have an outsized risk of developing cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David C Dreyfuss, MD 161 Riverside Dr, Suite 105, Binghamton, NY 13905-4176 Ph: (607) 770-9471 | Dr David C Dreyfuss, MD 161 Riverside Dr, Suite 105, Binghamton, NY 13905-4176 Ph: (607) 770-9471 |
News Archive
Physicians at Mayo Clinic's Florida campus are among the first in the nation to use a technique known as MRI-guided laser ablation to heat up and destroy kidney and liver tumors. So far, five patients have been successfully treated meaning no visible tumors remained after the procedure.
Ossianix, Inc. today announced a strategic research collaboration with Lundbeck A/S. This collaboration follows a previous investment in 2012. The collaboration uses Ossianix's innovative single domain antibody platform based on the shark VNAR structure and will focus on two projects.
Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.
Having problems with your health plan? If you speak up about it — or move on to another plan — you are a very unusual consumer, according to a new study.
Scientists know that age and weight are risk factors in the development of cancer. That should mean that whales, which include some of the largest and longest-lived animals on Earth, have an outsized risk of developing cancer.
› Verified 3 days ago
Horng Chyi Tsai, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 16 Grand Blvd, Binghamton, NY 13905 Phone: 607-797-1112 Fax: 607-729-1507 | |
Dr. Todd V Prier, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 169 Riverside Dr, Acc Building, Binghamton, NY 13905 Phone: 607-352-3550 | |
Dr. Eric Veilleux, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 169 Riverside Dr, Riverside Surgical, Binghamton, NY 13905 Phone: 607-352-3550 | |
Walid Hammoud, MD Surgery Medicare: Medicare Enrolled Practice Location: 33 Mitchell Ave, Suite 204, Binghamton, NY 13903 Phone: 607-762-2333 | |
Dr. James George Macconchie Iii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 169 Riverside Dr, Binghamton, NY 13905 Phone: 607-798-5111 | |
Michael A Bogdasarian, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 161 Riverside Dr, Suite 105, Binghamton, NY 13905 Phone: 607-770-9471 Fax: 607-797-4699 |